TrialHuman vaccines & immunotherapeutics2021

Safety and immunogenicity of a novel oral hexavalent rotavirus vaccine：a phase I clinical trial.

Zhi-Wei Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.